Granulocyte Colony Stimulating Factor (G-CSF) Induced Splenic Infarction in Breast Cancer Patient Treated with Dose-Dense Chemotherapy Regimen
Introduction. Granulocyte colony-stimulating factor (G-CSF) is commonly used for prevention and treatment of febrile neutropenia among solid tumor patients. It is considered an effective and relatively safe supportive care medication; however, it can cause rare and serious side effects such as splee...
Main Authors: | Majed A. Alshamrani, Meteb Al-Foheidi, Ahmed H. Abdulrahim |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/8174986 |
Similar Items
-
Comparison of the effects of pegylated granulocyte-colony stimulating factor and granulocyte-colony stimulating factor on cytopenia induced by dose-dense chemotherapy in breast cancer patients
by: Farzaneh Ashrafi, et al.
Published: (2018-01-01) -
Utilization of the Granulocyte Colony-stimulating Factors (G-CSF) for Managing Chemotherapy-induced Neutropenia in Breast Cancer Patients
by: Xing-LuJiang, et al.
Published: (2011) -
High-doses Granulocyte Colony-stimulating Factor (G-CSF) Benefit Elderly Patients with Acute Myeloid Leukemia
by: LI Wei, et al.
Published: (2018-05-01) -
Granulocyte colony-stimulating factor (G-CSF) mediates bone resorption in periodontitis
by: Hui Yu, et al.
Published: (2021-06-01) -
Expression and Purification of Recombinant Human Granulocyte Colony Stimulating Factor (hG-CSF).
by: Ming-Yang Chien, et al.
Published: (2008)